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OFP-12-001
Recombinant human erythropoietin treatment in a rat model of
nephrectomy
S. Ribeiro*, H. Vala, P. Garrido, J. Fernandes, E. Costa, L. Belo, F. Reis,
A. Santos Silva
*IUCIBIO, REQUIMTE, Laboratory of Biochemistry, University of
Porto, Portugal
Objective:We aimed to evaluate the impact of rHuEPO on anemia, renal
function and structure in chronic renal failure (CRF), using a rat model of
nephrectomy.
Method:Male Wistar rats, 12 weeks old, were divided in 3 groups: CRF
(induced by a two-stage 5/6 nephrectomy); rHuEPO-CRF (treated with
100 IU/kg/week during 3 weeks) and Sham (surgery without mass
reduction). Hematological and biochemical studies were per-
formed. Kidney tissue sections were stained with Periodic acid-
Schiff for histological studies. Statistical analysis were performed
using the Mann-Whitney test.
Results: At the end of protocol, CRF group presented anemia (p < 0.05)
and reduced glomerular filtration rate (GFR), whereas rHuEPO-CRF
group showed an improvement in hematological parameters
(p < 0.05) and a slight improvement in GFR. The histopatholog-
ical analysis of kidney tissue showed that CRF group presented
global glomerulosclerosis, tubular necrosis, IFTA and arteriolosclerosis.
Due to surgery, we also found some inflammatory cell infiltration.
The rHuEPO-CRF group presented mesangial expansion and a
reduction in tubulointerstitial and vascular lesions, as compared
to CRF rats.
Conclusion: The introduction of rHuEPO corrects the anemia associated
with renal failure and improved the degree of renal lesions, slowing the
progress of renal failure.
OFP-12-002
Role of macrophage differentiation in the pathogenesis of Lupus
nephritis
K. Amann*, G. Olmes, F. Ferrazzi, C. Daniel, M. Büttner-Herold
*Universität Erlangen-Nürnberg, Institut für Nephropathologie, Germany
Objective: The role of macrophages in particular their differentiation
(e.g. M1 or M2) in lupus nephritis is unknown. We investigated if mac-
rophage differentiation is associated with stage of lupus nephritis and
clinical parameters.
Method: 69 renal biopsies with lupus nephritis (ISN/RPS classes II-V)
were assessed for M1(iNOS/CD68), M2a(CD206/CD68) and
M2c(CD163/CD68). Blood pressure, proteinuria and serum urea were
correlated using Spearman-test. Cluster analysis was used to define
Lupus nephritis subtypes by macrophage activation markers.
Results: The mean number of CD68+macrophages was related to
ISN/RPS class with the highest macrophage infiltration in diffuse
proliferative class IV and the lowest number in class V. In all
ISN/RPS classes more CD163+/CD68+ M2c-like than CD206+/
CD68+ M2a-like cells were seen. We predominantly detected
M2-macrophages independent of ISN/RPS classification. The ma-
jority of M2a- and M2c-macrophages were localized in the
tubulointerstitium. Using data for macrophage activation markers,
3 different clusters were described. Interestingly, some beeing domi-
nated by one ISN/RPS-class; e.g. >75 % of patients from cluster 1 were
allocated to ISN/RPS class IV. Serum creatinine correlated positively with
the number of CD68+ (r = 0.411; p < 0.002) and CD206+/CD68+ M2a-
like macrophages in the tubulointerstitium (r = 0.441; p = 0.001). The
number of tubular CD163+/CD68+ M2c-like cells was related to serum
urea (r = 0.611;p = 0.001). Mean number of CD206+/CD68+macro-
phages was sig. higher in hypertensive compared to normotensive pa-
tients (p < 0.007).
Conclusion:M2-typemacrophages are key players in lupus nephritis and
macrophage subpopulations seem to be involved in the development of
disease progressing hypertension.
OFP-12-003
Effect of chronic therapy with chaethomellic acid A on renal fibrosis
in 5/6 nephrectomized rats: A preliminary study
A. Nogueira*, H. Vala, C. Nobrega, C. A. Pires, B. Colaço, P. A. Oliveira,
M. J. Pires
*CITAB, Dept. of Therapeutic and Diagn. Tech., Bragança, Portugal
Objective: The high prevalence of chronic kidney disease underscores
the failure to provide therapies to effectively halt, prevent, and/or reverse
renal fibrosis. Thus, the aim of this study was to evaluate the effect of
chronic treatment with chaethomellic acid A (CA) on renal fibrosis asso-
ciated to 5/6 nephrectomy.
Method:Male Wistar rats were subjected to 5/6 nephrectomy (RMR) or
sham-operated (SO). One week after surgery, rats were placed in four
experimental groups: RMR: rats without treatment (n = 13);
RMR+CA: rats treated with CA (n = 13); SO: rats without treat-
ment (n = 13); SO+AC: rats treated with CA (n = 13). CA was
intraperitoneally administered in a dose of 0.23 μg/Kg three times
a week for 6 months. Renal samples were scored for the follow-
ing lesions: glomerulosclerosis, interstitial fibrosis, arteriolosclerosis
and interstitial inflammation.
Results: Animals from the SO and SO+AC groups presented no kidney
histological changes. Glomerulosclerosis, interstitial fibrosis and
arteriolosclerosis scores were significantly lower (p < 0.001) in RMR+
AC group when compared with RMR group. There were no significantly
differences in interstitial inflammation score between RMR+AC and
RMR groups.
Conclusion: This preliminary data suggests that pharmacological inhibi-
tion of Ras (small GTPase proteins) activation may be a future strategy in
the prevention of renal fibrosis.
OFP-12-004
Polyvinylpyrrolidone storage disease in opioid addicted patients
H. Grønseth*, F. J. Leh, T. Bjånes, C. Ohldieck, E. Svarstad, S. M. Leh
*Haukeland University Hospital, Dept. of Pathology, Bergen, Norway
Objective: Opioid addicted patients may inject oral substitution drugs
such as methadone or buprenorphine. Some of these drugs contain high
molecular polyvinylpyrrolidone (PVP) as an excipient, which is not ex-
creted from the body when given intravenously. PVP deposition is diag-
nosed histologically by characteristic macrophages with bluish, vacuolat-
ed cytoplasm in various tissues. We present a biopsy series from opioid
addicted patients showing renal insufficiency as a main clinical sign of
PVP deposition disease.
Method: Biopsies (n = 28) and one autopsy with characteristic PVP
deposition were collected between 2009 and 2013, from 13 opioid
addicted patients (mean age 38 years, 12 males, 1 female).
Results: Renal biopsies (n = 8) showed interstitial PVP storing macro-
phages accompanied by various degrees of tubular atrophy and signs of
glomerular hypoperfusion. Other main biopsy sites showing the charac-
teristic macrophages were bone/bone marrow (n = 11) and the gastroin-
testinal tract (n = 5). Main clinical signs were reduced kidney function
(mean serum creatinine 219 micromol/L) and anemia (mean hemoglobin
9.9 g/dL). Abdominal discomfort and fractures were found sporadically.
Two patients died. One autopsy confirmed PVP deposition as underlying
cause of death.
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